As the U.S. stock market pulls back from recent record highs, investors are closely monitoring economic indicators and Federal Reserve policies that could influence future trends. In this environment, identifying stocks that may be trading below their fair value can present opportunities for those looking to capitalize on potential market inefficiencies.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Clear Secure (NYSE:YOU) | $26.98 | $53.27 | 49.4% |
UMB Financial (NasdaqGS:UMBF) | $122.36 | $244.39 | 49.9% |
Business First Bancshares (NasdaqGS:BFST) | $28.29 | $55.10 | 48.7% |
West Bancorporation (NasdaqGS:WTBA) | $23.59 | $46.42 | 49.2% |
Equity Bancshares (NYSE:EQBK) | $46.75 | $92.77 | 49.6% |
U.S. Physical Therapy (NYSE:USPH) | $94.06 | $187.03 | 49.7% |
Constellium (NYSE:CSTM) | $11.31 | $22.03 | 48.7% |
Freshpet (NasdaqGM:FRPT) | $145.69 | $283.12 | 48.5% |
Equifax (NYSE:EFX) | $265.29 | $529.48 | 49.9% |
Marcus & Millichap (NYSE:MMI) | $40.82 | $81.04 | 49.6% |
Click here to see the full list of 194 stocks from our Undervalued US Stocks Based On Cash Flows screener.
We'll examine a selection from our screener results.
Overview: Veracyte, Inc. is a diagnostics company that operates in the United States and internationally, with a market cap of $3.37 billion.
Operations: The company generates revenue from its Diagnostic Products segment, amounting to $425.33 million.
Estimated Discount To Fair Value: 16.6%
Veracyte's recent financial performance indicates a positive turnaround with a net income of US$15.16 million in Q3 2024, compared to a loss last year. The company raised its revenue guidance for 2024, reflecting strong growth prospects. Although trading below fair value by approximately 16.6%, Veracyte's shares have experienced dilution over the past year. With expected annual profit growth above market averages and improving cash flows, Veracyte presents potential undervaluation based on these metrics.
Overview: CoStar Group, Inc. offers information, analytics, and online marketplace services to professionals in the commercial real estate, hospitality, and residential sectors across various regions including the United States, with a market cap of approximately $31.80 billion.
Operations: The company's revenue segment includes Internet Information Providers, generating $2.67 billion.
Estimated Discount To Fair Value: 23.3%
CoStar Group's stock, trading at US$78.25, is undervalued by over 20% based on discounted cash flow analysis with a fair value estimate of US$101.99. Despite a decline in profit margins from 16.9% to 6.6%, earnings are expected to grow significantly at over 42% annually, outpacing the market average. Recent strategic moves include acquiring prime office space in Arlington for headquarters relocation, enhancing operational efficiency amidst ongoing revenue growth and expansion efforts.
Overview: Paycor HCM, Inc. provides human capital management solutions for small and medium-sized businesses in the United States and has a market cap of approximately $3.52 billion.
Operations: The company's revenue is primarily derived from its Internet Software & Services segment, which generated $678.84 million.
Estimated Discount To Fair Value: 47.4%
Paycor HCM's stock, priced at US$20.25, is undervalued by over 47% with a fair value estimate of US$38.47 based on discounted cash flow analysis. Revenue growth is projected at 10.4% annually, surpassing the overall market rate and indicating strong future prospects as earnings are expected to grow significantly by 56.58% per year. Recent innovations like Paycor Assistant and an Integration Platform enhance operational capabilities, positioning the company for strategic growth in HR technology solutions.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGM:VCYT NasdaqGS:CSGP and NasdaqGS:PYCR.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.